Q2 2020

Filed Aug 14, 2020 · 10-Q · 45 days after period end · 0001477932-20-004877

Q2 2020 · 10-Q

Revenue

$33.70K

−48.9% vs Q2 2019

Net Income

-$738.48K

N/M vs Q2 2019

EPS Diluted

-$0.14

N/M vs Q2 2019

Operating Income-$2,154,217N/M

Operating Cash Flow

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2018	Q2 2017
Revenue	$33.70K	$65.98K	$98.67K	$210.54K
Net Income	-$738.48K	-$2.04M	-$1.22M	$11.30M
EPS Diluted	-$0.14	-$0.67	$0.00	$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR